Saturday, June 05, 2021 1:29:49 PM
8. The Company currently has five, (5) full time employees.
you will find that on page nine
https://backend.otcmarkets.com/otcapi/company/financial-report/283247/content
now that would be in the corporate office the rest of them would be in the manufacturing facility in India.
The Company’s strategic manufacturing facility in an area considered one of the safest and perfect for pharmaceutical
operations. The facility is approximately 5,500 square feet. In February 2009, SHMN’s manufacturing facility was
licensed by the India FDA. The license indicates compliance with Current Good Manufacturing Practice (CGMP)
Regulations: Division of Manufacturing and Product Quality and compliant with World Health Organization (WHO)
regulations and FDA
source page ten
https://backend.otcmarkets.com/otcapi/company/financial-report/283247/content
you will find that on page nine
https://backend.otcmarkets.com/otcapi/company/financial-report/283247/content
now that would be in the corporate office the rest of them would be in the manufacturing facility in India.
The Company’s strategic manufacturing facility in an area considered one of the safest and perfect for pharmaceutical
operations. The facility is approximately 5,500 square feet. In February 2009, SHMN’s manufacturing facility was
licensed by the India FDA. The license indicates compliance with Current Good Manufacturing Practice (CGMP)
Regulations: Division of Manufacturing and Product Quality and compliant with World Health Organization (WHO)
regulations and FDA
source page ten
https://backend.otcmarkets.com/otcapi/company/financial-report/283247/content
Recent SHMN News
- SOHM Inc. Releases White Paper on ABBIE, a Cas9-Guided Integrase Enabling Stable Gene Integration and Creation of SKOV3-GYS1 Cell Line for Drug Discovery • ACCESS Newswire • 11/06/2025 02:30:00 PM
- SOHM Notes FDA's Evolving Gene-Editing Framework in Context of Ongoing ABBIE Platform Development • ACCESS Newswire • 11/04/2025 02:30:00 PM
